Barbara Alm

Barbara Alm is a researcher at the Central Institute of Mental Health (ZI) in Mannheim, Germany, affiliated with the Department of Psychiatry and Psychotherapy. She specializes in ADHD in adulthood, focusing on clinical trials, psychotherapy efficacy, and pharmacological interventions.

• Key contributor to the COMPAS and AIMAC multicenter studies
• Research spans methylphenidate safety, therapy adherence, and intergenerational ADHD treatment

Research Interests: Her work addresses clinical outcomes in adult ADHD patients, combining psychotherapy and medication. She investigates treatment acceptability, long-term pharmacological safety, and family-based interventions.

Publications: Active in peer-reviewed journals since 2006, with a focus on randomized controlled trials and translational psychiatry. Notable collaborations include studies on maternal ADHD impacting child outcomes.